700 participants
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-19
- Start Date:
- 2025-03-27
- Completion:
- 2029-05-31
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG
No Results Yet